A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
On December 31, 2019, pneumonia due to the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2, formerly known as 2019-nCoV) appeared to Wuhan, China, and COVID-19 is an infectious disease caused by SARS. CoV-2. SARS-CoV-2 is a new strain of coronavirus that has not been previously identified in humans. Until April 18, 2020, 2275783 were confirmed and 156104 deaths worldwide reported. This paper presents an overview of the findings that scientists have realized so far. In this study articles indexed in Embase, Elsevier, PubMed, Google Scholar and using keywords SARS-CoV-2, COVID-19, Coronavirus 2019 and nCoV-2019 were used. The World Health Organization and the Centers for Disease Control and Prevention used the world's most reputable websites to obtain the latest COVID-19 disease statistics. In the initial search, 500 articles were extracted and 55 articles were selected after duplication and evaluation of title and abstract. The results show that the mortality rate of the virus in the elderly and people with underlying diseases is significantly higher than in the healthy ones. High-risk groups for the disease include cardiovascular disease, diabetes, chronic respiratory disease, and hypertension, respectively. The novel coronavirus pandemic is more widespread in humans compared to previous coronaviruses, which indicates the extremely high prevalence of the virus. No vaccine or cure has been found for the virus so far, but supportive treatments and early diagnosis are effective in the treatment process, and there are many treatments around the world for the treatment of COVID-19..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Iranian Journal of Medical Microbiology - 14(2020), 2, Seite 154-161 |
| Sprache: |
Englisch ; Persisch |
|---|
| Beteiligte Personen: |
Farzaneh Mohammadzadeh rostami [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Themen: |
2019 novel coronavirus disease |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ002875268 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ002875268 | ||
| 003 | DE-627 | ||
| 005 | 20230309172320.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ002875268 | ||
| 035 | |a (DE-599)DOAJc5ce31d518e94a858be54f7497399005 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a per | ||
| 050 | 0 | |a QR1-502 | |
| 100 | 0 | |a Farzaneh Mohammadzadeh rostami |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a On December 31, 2019, pneumonia due to the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2, formerly known as 2019-nCoV) appeared to Wuhan, China, and COVID-19 is an infectious disease caused by SARS. CoV-2. SARS-CoV-2 is a new strain of coronavirus that has not been previously identified in humans. Until April 18, 2020, 2275783 were confirmed and 156104 deaths worldwide reported. This paper presents an overview of the findings that scientists have realized so far. In this study articles indexed in Embase, Elsevier, PubMed, Google Scholar and using keywords SARS-CoV-2, COVID-19, Coronavirus 2019 and nCoV-2019 were used. The World Health Organization and the Centers for Disease Control and Prevention used the world's most reputable websites to obtain the latest COVID-19 disease statistics. In the initial search, 500 articles were extracted and 55 articles were selected after duplication and evaluation of title and abstract. The results show that the mortality rate of the virus in the elderly and people with underlying diseases is significantly higher than in the healthy ones. High-risk groups for the disease include cardiovascular disease, diabetes, chronic respiratory disease, and hypertension, respectively. The novel coronavirus pandemic is more widespread in humans compared to previous coronaviruses, which indicates the extremely high prevalence of the virus. No vaccine or cure has been found for the virus so far, but supportive treatments and early diagnosis are effective in the treatment process, and there are many treatments around the world for the treatment of COVID-19. | ||
| 650 | 4 | |a covid19 | |
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a 2019 novel coronavirus disease | |
| 650 | 4 | |a covid-19 pandemic | |
| 653 | 0 | |a Microbiology | |
| 700 | 0 | |a Bahram Nasr Nasr Esfahani |e verfasserin |4 aut | |
| 700 | 0 | |a Ali Mohammad Ahadi |e verfasserin |4 aut | |
| 700 | 0 | |a Saman Shalibeik |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Iranian Journal of Medical Microbiology |d Farname, 2015 |g 14(2020), 2, Seite 154-161 |w (DE-627)DOAJ000088986 |x 23454342 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2020 |g number:2 |g pages:154-161 |
| 856 | 4 | 0 | |u https://doaj.org/article/c5ce31d518e94a858be54f7497399005 |z kostenfrei |
| 856 | 4 | 0 | |u http://ijmm.ir/article-1-1132-en.html |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1735-8612 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2345-4342 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2020 |e 2 |h 154-161 | ||